{
    "xml": "<topic id=\"PHP33678\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/linaclotide\" basename=\"linaclotide\" title=\"LINACLOTIDE\">\n<title>LINACLOTIDE</title>\n<body>\n<data name=\"vtmid\">21991511000001105</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_778338257\" title=\"Guanylate cyclase-C receptor agonists\">Guanylate cyclase-C receptor agonists</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP44030\" outputclass=\"indicationsAndDose\" rev=\"1.12\" parent=\"/drugs/linaclotide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Moderate to severe irritable bowel syndrome with constipation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>290&#8239;micrograms once daily, review treatment if no response after 4 weeks.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP44077\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drugs/linaclotide\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Gastro-intestinal obstruction</ph>; <ph outputclass=\"contraindication\">inflammatory bowel disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP44094\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/linaclotide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Predisposition to fluid and electrolyte disturbances</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43961\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/linaclotide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal distension</ph>; <ph outputclass=\"sideEffect\">abdominal pain</ph>; <ph outputclass=\"sideEffect\">diarrhoea (if severe or prolonged, consider suspending treatment)</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Decreased appetite</ph>; <ph outputclass=\"sideEffect\">dehydration</ph>; <ph outputclass=\"sideEffect\">hypokalaemia</ph>; <ph outputclass=\"sideEffect\">orthostatic hypotension</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP44004\" outputclass=\"pregnancy\" parent=\"/drugs/linaclotide\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP44104\" outputclass=\"breastFeeding\" parent=\"/drugs/linaclotide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Unlikely to be present in milk in significant amounts, but manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58043\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/linaclotide\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dispense capsules in original container (contains desiccant); discard any capsules remaining 18 weeks after opening.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43838\" outputclass=\"nationalFunding\" rev=\"1.11\" parent=\"/drugs/linaclotide\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (May 2013) that linaclotide (<i>Constella</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for moderate to severe irritable bowel syndrome in patients whose condition has not responded adequately to all other treatments, or who are intolerant of them.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP33678-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/linaclotide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76936\" title=\"Capsule\" namespace=\"/drugs/linaclotide/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78139\" namespace=\"/treatment-summaries/chronic-bowel-disorders\" title=\"Chronic bowel disorders\" count=\"1\" rel=\"backlink\">Chronic bowel disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78233\" namespace=\"/treatment-summaries/constipation\" title=\"Constipation\" count=\"1\" rel=\"backlink\">Constipation</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76936\" namespace=\"/drugs/linaclotide/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP33678",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/linaclotide",
    "basename": "linaclotide",
    "title": "LINACLOTIDE",
    "vtmid": "21991511000001105",
    "drugClassification": [
        "Guanylate cyclase-C receptor agonists"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Moderate to severe irritable bowel syndrome with constipation",
                        "html": "Moderate to severe irritable bowel syndrome with constipation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "290 micrograms once daily, review treatment if no response after 4 weeks.",
                        "html": "<p>290&#8239;micrograms once daily, review treatment if no response after 4 weeks.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Gastro-intestinal obstruction",
                "html": "Gastro-intestinal obstruction"
            },
            {
                "type": "contraindications",
                "textContent": "inflammatory bowel disease",
                "html": "inflammatory bowel disease"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Predisposition to fluid and electrolyte disturbances",
                "html": "Predisposition to fluid and electrolyte disturbances"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal distension",
                        "html": "Abdominal distension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "abdominal pain",
                        "html": "abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea (if severe or prolonged, consider suspending treatment)",
                        "html": "diarrhoea (if severe or prolonged, consider suspending treatment)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Decreased appetite",
                        "html": "Decreased appetite",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dehydration",
                        "html": "dehydration",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypokalaemia",
                        "html": "hypokalaemia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "orthostatic hypotension",
                        "html": "orthostatic hypotension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid.",
                "html": "<p>Manufacturer advises avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Unlikely to be present in milk in significant amounts, but manufacturer advises avoid.",
                "html": "<p>Unlikely to be present in milk in significant amounts, but manufacturer advises avoid.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dispense capsules in original container (contains desiccant); discard any capsules remaining 18 weeks after opening.",
                "html": "<p>Dispense capsules in original container (contains desiccant); discard any capsules remaining 18 weeks after opening.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (May 2013) that linaclotide (Constella ) is accepted for restricted use within NHS Scotland for moderate to severe irritable bowel syndrome in patients whose condition has not responded adequately to all other treatments, or who are intolerant of them.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (May 2013) that linaclotide (<i>Constella</i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for moderate to severe irritable bowel syndrome in patients whose condition has not responded adequately to all other treatments, or who are intolerant of them.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76936",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78139",
                "label": "Chronic bowel disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78233",
                "label": "Constipation",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76936",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}